Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6 Hold
8
﹤0.01% 894
2026
Q1
$6 Buy
+8
New +$7 ﹤0.01% 872
2025
Q2
Sell
-8
Closed -$16 951
2025
Q1
$16 Hold
8
﹤0.01% 917
2024
Q4
$26 Hold
8
﹤0.01% 1003
2024
Q3
$32 Hold
8
﹤0.01% 772
2024
Q2
$40 Hold
8
﹤0.01% 777
2024
Q1
$63 Hold
8
﹤0.01% 731
2023
Q4
$70 Hold
8
﹤0.01% 735
2023
Q3
$70 Hold
8
﹤0.01% 776
2023
Q2
$94 Hold
8
﹤0.01% 793
2023
Q1
$585 Hold
8
﹤0.01% 787
2022
Q4
$681 Hold
8
﹤0.01% 659
2022
Q3
$1K Hold
8
﹤0.01% 635
2022
Q2
$1K Hold
8
﹤0.01% 771
2022
Q1
$3K Hold
8
﹤0.01% 662
2021
Q4
$3K Buy
8
+5
+167% +$2.91K ﹤0.01% 621
2021
Q3
$2K Hold
3
﹤0.01% 600
2021
Q2
$3K Hold
3
﹤0.01% 568
2021
Q1
$4K Buy
+3
New +$4.36K ﹤0.01% 513

Other funds holding YCBD

HHM Wealth Advisors's YCBD Position: Q2 2026 in Review

HHM Wealth Advisors held its cbdMD (YCBD) position steady in Q2 2026 at 8 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #894.

HHM Wealth Advisors first reported a position in YCBD in Q1 2021 and has held it in 19 quarters since. The position peaked at $4K in Q1 2021. 4 funds tracked by Wall St. Rank hold YCBD as of Q2 2026.

  • HHM Wealth Advisors held 8 shares of cbdMD worth $6 as of Q2 2026.
  • HHM Wealth Advisors left its cbdMD share count unchanged in Q2 2026.
  • cbdMD made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #894 holding.
  • HHM Wealth Advisors first reported a position in cbdMD in Q1 2021 and has held it in 19 quarters since.
  • HHM Wealth Advisors's cbdMD position peaked at $4K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held cbdMD as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.